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• The relation between cardiorespiratory fitness (CRF) and venous thromboembolism (VTE) is 
unsure. 
• CRF was estimated, and the association between age-predicted CRF and VTE risk was 
investigated 
• Compared to <85%, a CRF of 85-100% and >100% of predicted was related to 46% and 67% 
lower risk 








Background: Cardiorespiratory fitness (CRF) is a strong predictor of future arterial cardiovascular 
disease and premature mortality. However, there is limited data on the association between CRF and 
the risk of incident venous thromboembolism (VTE). 
Objectives: To investigate whether estimated CRF (eCRF) was associated with the risk of incident VTE 
in a cohort recruited from the general population. 
Methods: Participants (n=10,393) from the sixth survey of the Tromsø Study (2007-08) were included, 
and incident VTEs were recorded up to December 31, 2016. eCRF was estimated in sex-specific 
algorithms based on age, waist circumference, resting heart rate and self-reported physical activity. 
Hazard ratios (HRs) with 95% confidence intervals (CIs) of VTE according to categories of eCRF were 
calculated in Cox regression models adjusted for sex with age as timescale. The impact of weight status 
was evaluated in analyses stratified by weight category. 
Results: There were 176 incident VTEs during follow-up. Compared with individuals with eCRF <85% 
of age-predicted, those with eCRF of 85-100% and >100% of age-predicted had 46% (HR 0.54; 95% CI 
0.39-0.77) and 67% (HR 0.33; 95% CI 0.20-0.54) lower VTE risk, respectively. Compared with 
overweight/obese individuals with eCRF <85% of age-predicted, overweight/obese with eCRF ≥85% 
had 50% (HR 0.50, 95%CI 0.35-0.74) lower risk, and normal weight individuals with eCRF ≥85% had 55% 
(HR 0.45, 95% CI 0.30-0.68) lower risk. 
Conclusions: Higher eCRF was associated with lower risk of incident VTE. The association was 
independent of weight categories, suggesting that higher eCRF may modify the association between 






Venous thromboembolism (VTE) occurs in 1-2 per 1000 individuals annually, and is the third most 
common lethal cardiovascular disease (CVD) after myocardial infarction and stroke [1-3]. VTE is not 
only a potentially fatal disease, but is also associated with debilitating complications, high recurrence 
rates, and regarded a significant contributor to the global burden of disease [4-6]. Moreover, with an 
aging population and a rising prevalence of obesity and cancer, the incidence of VTE is expected to 
increase in the coming years [7-9]. Identification of modifiable risk factors at the population level is 
currently a priority to curb the growing burden of VTE. 
 A wealth of evidence support that regular physical activity is beneficial in the prevention of 
arterial CVD, some cancers and type-2 diabetes, as well as for increased longevity [10, 11]. Emerging 
data also support that physical activity is associated with a lower risk of incident VTE [12-15], although 
there is some controversy in the literature [1, 16, 17]. In a recent narrative review, we summarized the 
available data, and concluded that the current literature is balanced towards a small beneficial effect 
of physical activity [18]. Important challenges in research on physical activity include inconsistent 
definitions, a variety of available instruments, and the reliance on self-reported data [18, 19]. 
Combined with differences in study design and populations, these challenges may account for the 
inconsistent literature on physical activity and VTE risk, and studies utilizing objective assessment 
strategies are warranted [18]. 
 Cardiorespiratory fitness (CRF) relates to the ability of the circulatory, respiratory and muscular 
systems to supply and consume oxygen during sustained physical activity, and is quantified as maximal 
oxygen uptake (VO2max) in L/min or mL/kg/min [20, 21]. Similar to insufficient physical activity, low CRF 
is associated with higher risk and less favorable outcomes in arterial CVD and cancer [22-25]. CRF 
largely reflects the level of habitual physical activity of an individual, but is also influenced by age, sex, 
genetic architecture, comorbidities, as well as body size and composition [21, 26]. Although the gold 
standard for assessment of CRF is through direct measurement of oxygen uptake by ventilatory expired 
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gas analysis during a maximal exercise test [27], such testing is time and resource demanding and may 
not be feasible in clinical- and research settings [22]. Therefore, algorithms have been developed to 
estimate CRF, and these correlate well with objectively assessed CRF and appear to be robust health 
indicators [22, 28-30].  Importantly, CRF is reported to be a stronger predictor than physical activity for 
several health outcomes, such as coronary heart disease and all-cause mortality [31-33]. 
 Two previous studies have addressed the association between CRF and risk of incident VTE. 
Based on data from a Swedish cohort of male conscripts (aged 18-20 years), Zöller et al. reported that 
higher weight-adjusted maximal workload on a cycle ergonometric test (Wattmax/kg) was associated 
with lower risk of unprovoked incident VTE [34].  Further, Kunutsor et al. found a non-significant lower 
VTE risk in middle-aged (42-61 years) men in the highest tertile of weight-adjusted maximal oxygen 
uptake assessed on a cycle ergonometric test [35]. A limitation of the former study was that 80% of 
the VTEs occurred before the age of 50 (maximal attained age at the end of follow-up was 56 years), 
whereas both studies were restricted to men only [34, 35].Thus, it still remains to be established 
whether CRF relates to VTE risk, and whether an association is influenced by gender. Therefore, the 
aims of the present study were (i) to investigate the association between estimated CRF (eCRF) and 
the risk of incident VTE in a cohort recruited from the general population, and (ii) to explore whether 
a potential association was influenced by weight as body weight is associated with both CRF and VTE 




The Tromsø Study, initiated in 1974, is a large population-based cohort study with repeated health 
surveys of the inhabitants of Tromsø, Norway. Seven surveys have been completed so far (2019), and 
the present study was based on 12,981 participants enrolled in the sixth survey in 2007-08. Detailed 
methodology of the Tromsø Study has been published elsewhere [37]. Briefly, total- or samples of total 
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birth cohorts of subjects within the age range 30-87 years were invited, and the attendance rate was 
66%. Individuals not officially registered as inhabitants of the Tromsø municipality at baseline (n=6), 
with a history of VTE (n=182) or with missing data on variables required for estimating CRF (i.e. age, 
waist circumference, physical activity and resting heart rate; n=2,400) were excluded. Consequently, 
10,393 individuals were included in the analyses. A comparison of included and excluded participants 
is shown in Table S1. Excluded participants were older, had a larger waist circumference and a less 
favorable cardiovascular risk profile compared with those included. Additionally, the fraction with 
higher education was lower, and the prevalence of CVD was higher among the excluded. Excluded 
participants with data on physical activity were more active compared with the included participants. 
Notably, such data were only available in 421 individuals, and these appeared to be a young selection 
of the excluded participants (mean age was 53.9 ± 13 years). The study was approved by the Regional 
Committee for Medical and Health Research Ethics, and all participants provided written informed 
consent prior to inclusion.  
 
Measurements 
Baseline information was collected from physical examinations, blood samples and self-administered 
questionnaires. Height, weight, blood pressure and resting heart rate were measured with 
standardized procedures, as previously described [36]. Body mass index (BMI) was calculated as weight 
in kilograms divided by the square of height in meters (kg/m2), and participants were classified as 
normal weight (BMI <25), overweight (BMI 25-29.9) or obese (BMI ≥30) [38]. Information on leisure-
time physical activity, smoking habits, education and history of cardiovascular disease (CVD; angina 
pectoris, myocardial infarction and stroke) was obtained from self-administered questionnaires [13, 
37]. The questions on physical activity were related to weekly frequency (never, less than once, once, 
2-3 times or approximately every day), duration per session (<15 min, 15-29 min, 30-60 min or >1 hour, 
and intensity (not short-winded or sweaty, becoming short-winded or sweaty or becoming exhausted). 
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A summary physical activity index was calculated by multiplying weighted values of the responses to 
these questions (Table S2) [39]. Data on cancer was obtained from the Cancer Registry of Norway. 
Estimated cardiorespiratory fitness 
Cardiorespiratory fitness was estimated from sex-specific algorithms based on age, waist 
circumference, resting heart rate and physical activity index [39]. These algorithms were developed 
and validated in a Norwegian population-based cohort with a wide age-range (20-90 years), and CRF 
estimated from this model has been shown to predict cardiovascular and all-cause mortality [28, 40]. 
The algorithms for estimating CRF (in mL/kg/min) were [39]: 
 
 Women (R2 0.56, standard error of estimate (SEE) 5.14): 74.74 - (0.247 × age) – (0.259 × waist 
circumference) - (0.114 × resting heart rate + (0.198 × physical activity index) 
 Men (R2 0.61, SEE 5.70): 100.27 - (0.296 × age) – (0.369 × waist circumference - (0.155 × resting 
heart rate) + (0.226 × physical activity index) 
 
 In addition, the expected CRF (CRFpred) according to age was calculated for each participant 
with the formula 55.6 - (0.328 x age) for women, and 63.6 - (0.393 x age) for men [28]. Based on the 
fraction of age-predicted CRF (eCRF/CRFpred*100%), the participants were divided into three categories 
with cut-offs at 85% and 100% [28]. eCRF was also expressed as a multiples of the resting metabolic 
equivalent (MET). One MET is approximately 3.5 mL/kg/min, and regarded as a clinically significant 
change in CRF [22]. Further, the participants were  categorized according to sex- and age- (by ten years) 
specific quintiles into low eCRF (<20th percentile), moderate eCRF (20-60th percentile) and high eCRF 




Identification and adjudication of venous thromboembolism 
Incident VTE events during follow-up were identified by searching the hospital discharge registry, the 
radiology procedure registry and the autopsy registry at the University Hospital of North Norway 
(UNN). UNN is the exclusive provider of hospital care and diagnostic radiology in the study region, and 
the discharge registry comprises both outpatient visits and hospitalizations. Trained personnel 
reviewed the medical records and adjudicated potential VTE cases. The adjudication criteria were a 
combination of: signs and symptoms of PE or DVT, presence of a thrombus confirmed by radiology, a 
diagnosis of PE or DVT in the patient’s medical record, and initiation of treatment (unless 
contraindications were specified). DVTs in the upper and lower extremities and in other locations (e.g. 
visceral veins) were included. The process of identification and adjudication of VTE events in the 
Tromsø Study has previously been described in detail [41]. 
 All VTEs were classified according to clinical presentation (i.e. DVT or PE with or without DVT), 
and according to the presence of provoking factors at the time of diagnosis. An event was classified as 
provoked in the presence of the following factors: surgery or trauma (within 8 weeks prior to the 
event), acute medical conditions (acute myocardial infarction, ischemic stroke, or major infectious 
disease), active cancer, marked immobilization (bedrest ≥3 days, confined to wheelchair, or long-
distance travel ≥4 h within the previous 14 days), or another provoking factor described by the 




For each participant, person-years of follow-up were accrued from the date of enrollment in Tromsø 
6 (2007-08) to the date of incident VTE, migration, death or the end of the study period (December 31, 
2016), whichever occurred first. During follow-up, 630 participants were censored due to migration 
and 410 due to death. 
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 Crude incidence rates (IRs) with 95% confidence intervals (CIs) were calculated and expressed 
as number of events per 1000 person-years. Cox proportional hazards regression models were used to 
estimate hazard ratios (HRs) with 95% CIs for total VTE, provoked and unprovoked VTE, and for PE and 
DVT. HRs were estimated according to categories of the fraction of age-predicted CRF, by age- and sex-
specific categories of eCRF and per MET increase. The lowest category was used as the reference in 
the categorical analyses. Age was used as the timescale, with the age at enrollment defined as entry 
time and the age at VTE or censoring defined as exit time.  The analyses were performed in two models. 
The basic modelwas adjusted for age (as timescale) and sex, and the multivariable model was further 
adjusted for smoking, education, history of cardiovascular disease and history of cancer. The analyses 
of age- and sex-specific categories eCRF were not additionally adjusted for sex. Individuals (n=79) with 
missing information on one or more covariates in the multivariable model were omitted from this 
analysis only. The impact of weight status on the association between eCRF and VTE risk was explored 
in analyses stratified according to BMI-categories (i.e. BMI <25 and BMI ≥25).  Statistical interaction 
between eCRF and sex was tested by including the cross-product term in the proportional hazards 
regression model and no interaction was found. The proportional hazards assumption was evaluated 
and verified on the basis of Schoenfeld residuals. The statistical analyses were performed with STATA 
version 15.1 (Stata Corp, College Station, TX, USA). 
 
Results 
The mean age at baseline was 56 ± 12 years, and 53.1% of the participants were women. Overall, mean 
eCRF was 31.5 ± 5.7 mL/kg/min in women and 38.8 ± 6.8 mL/kg/min in men. Baseline characteristics 
according to categories of fraction of age-predicted CRF are shown in Table 1, and baseline 
characteristics according to age- and sex-specific categories of eCRF are shown in Table S3. Absolute 
eCRF increased with increasing categories from 29.0 mL/kg/min in those with eCRF <85% of age-
predicted to 43.2 mL/kg/min in those with eCRF >100% of age-predicted. Women were 
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overrepresented in the lowest category (71.2%) and underrepresented in the highest category (19.6%). 
While the mean age was similar across categories, the cardiovascular risk profile was more favorable 
in the higher categories of fraction of age-predicted eCRF. The fraction with higher education increased 
across the categories, while the fraction of current smokers was lowest in the highest category. 
 During 83,729 person-years of follow-up (median duration: 8.5 years, interquartile range: 8.2-
8.9), there were 176 incident VTE events, yielding a crude IR of 2.1 (95% CI 1.8-2.4) per 1000 person-
years. Table 2 shows the characteristics of the VTE events. The mean age at incident VTE was 69 ± 11 
years, and 55.1% of the events occurred in men. The most common clinical presentation was PE with 
or without concomitant DVT accounting for 56.3% of the events, and the remaining 43.7% were 
isolated DVTs. Further, 60.8% of the events were classified as provoked with cancer as the most 
frequent provoking factor (30.7%). 
 Table 3 shows the association between the fraction of age-predicted CRF and VTE risk. 
Compared with those with eCRF <85% of age-predicted, individuals with eCRF between 85-100% and 
>100% of age-predicted values had 46% (HR 0.54; 95% CI 0.39-0.77) and 67% (HR 0.33; 95% CI 0.20-
0.54) lower VTE risk, respectively, in the age- and sex-adjusted model. Significant associations of 
comparable strength were observed for all outcomes, although those with eCRF >100% of age-
predicted appeared to have a substantially lower risk of unprovoked VTE (HR 0.22; 95% CI 0.09-0.54). 
The risk estimates were essentially unchanged after further adjustment for smoking, education, history 
of cardiovascular disease and history of cancer. Due to the unequal sex-distribution between the 
categories, the association between fraction of age-predicted CRF and the risk of total VTE was 
explored in sex-stratified Cox models. These showed similar trend as the main analyses, although a 
stronger association was suggested in women (Table S4). Each MET (approximately 3.5 ml/kg/min) 
increase in eCRF was associated with a significantly lower risk for all outcomes in the range 21-27%. 
 The impact of weight status on the association between eCRF and VTE was explored in analyses 
stratified by BMI-categories (Fig. 1). Compared with the reference group (i.e. overweight/obese 
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individuals with eCRF <85% of age-predicted), the risk of VTE was 50% (HR 0.50; 95% CI 0.35-0.74) 
lower among those in the same weight category but with eCRF ≥85% of age-predicted. For normal 
weight individuals with ≥85% of age-predicted eCRF, the risk was 55% lower (HR 0.45; 95% CI 0.30-
0.68), whereas normal weight individuals with <85% of age-predicted eCRF had comparable VTE risk 
as the reference group (HR 1.06; 0.57-1.97). 
 HRs for the association between age- and sex-specific categories of eCRF and the risk of 
incident VTE are shown in Table S5. Compared with individuals with low eCRF, those with moderate 
and high levels had 37% (HR 0.63; 95% CI 0.44-0.90) and 54% (HR 0.46: 95% CI 0.32-0.68) lower risks, 
respectively, in the age-adjusted model. The strongest associations were observed in relation to 
unprovoked VTE and PE. The corresponding risk reduction for those with moderate and high eCRF were 
42% (HR 0.58; 95% CI 0.34-1.01) and 64% (HR 0.36; 95% CI 0.19-0.67) for unprovoked VTE, and 39% 
(HR 0.61; 95 CI 0.39-0.96) and 63% (HR 0.37; 95 CI 0.22-0.62) for PE. The risk estimates were essentially 
unchanged in after further adjustment for smoking, education, history of cardiovascular disease and 
history of cancer. 
 
Discussion 
In the present study of 10,393 participants recruited from the general population, we found that higher 
eCRF was associated with a lower risk of incident VTE. This finding was consistent across subcategories 
of VTE, and a beneficial association between high eCRF and VTE was observed in both normal weight 
and overweight/obese individuals. 
 To the best of our knowledge, the association between CRF and the risk of VTE has only been 
addressed in two previous studies. In a cohort of 777,925 men aged 18-20 years, Zöller et al. [34] found 
that one standard deviation increase in maximal workload on a cycle ergonometric test (Wmax/kg) was 
associated with 19% lower risk of unprovoked VTE. A direct comparison with our findings is challenging 
due to different methodology, however, both studies support that a higher fitness level is associated 
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with lower risk of incident VTE [34]. Our findings are also partly supported by Kunutsor et al. [35], who 
reported that men in the highest tertile of weight-adjusted CRF had a non-significant 20% lower risk of 
VTE. It was speculated that regression dilution due to a long follow-up (median: 25.2 years), limited 
statistical power and study population characteristics may have camouflaged an association [35]. In 
the present study, we extend previous findings by showing that eCRF was associated with lower VTE 
risk in individuals of both genders, through a wide age-range, across subcategories of VTE (i.e. 
unprovoked/provoked and DVT/PE) and in both normal weight and overweight/obese subjects. 
 We found that an eCRF ≥85% of age-predicted was associated with 46% lower risk, whereas 
eCRF >100% of age-predicted was associated with 67% lower risk, compared with eCRF <85% of age-
predicted. Likewise, moderate (20-60th percentile) and high (>60th percentile) eCRF according to age- 
and sex-specific categories was associated with 37% and 54% lower VTE risk, respectively, compared 
with low eCRF (<20th percentile). These risk estimates are somewhat larger than those observed in 
studies on physical activity and VTE, where risk reductions between 4% and 41% have been reported 
[12-15]. A stronger association between eCRF and VTE may be ascribed to several factors. First, 
information on habitual physical activity is commonly obtained through self-report [12-15], with an 
inherent chance of misclassification due to challenges with recall and social desirability [19]. In cohorts, 
such misclassification would be non-differential and presumably lead to underestimation of the true 
risk [42]. Thus, it is likely that the true association between physical activity and VTE is stronger than 
currently perceived. eCRF also comprises of additional components that are measured with a high level 
of precision, and that are well-established risk factors for VTE, such as waist circumference and age, 
which were the two most heavily weighted components in the eCRF algorithm. Obesity is associated 
with a two- to threefold increased risk of VTE, and among the obesity measures, waist circumference 
is reported to be the strongest predictor of VTE [43, 44]. Further, although VTE may occur at all ages, 
the incidence increases exponentially with age, and the risk in those ≥85 years is more than 12-fold 
higher than in those aged 45 to 55 years [3, 17]. Finally, as sizeable proportion of the variance in CRF 
may be ascribed to inherited factors, a highly active individual may have a relatively low level of fitness 
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and vice versa [21, 45]. Therefore, it has been suggested that physical activity and CRF may be 
considered as independent entities [31]. 
 Analyses stratified by BMI-categories revealed that eCRF may alter the relationship between 
weight status and VTE risk. Specifically, we found that overweight and obese individuals with ≥85% of 
age-predicted eCRF had comparable VTE risk as normal weight individuals, and that the risk in normal 
weight individuals with eCRF <85% was comparable to the risk in individuals with a high body weight. 
This suggests that the association between eCRF and VTE is independent of weight categories, and that 
higher eCRF may mitigate the elevated VTE risk in overweight/obesity. Similar observations have been 
made in relation to other major health outcomes, including all-cause and CVD-mortality, and CRF is 
also reported to influence the obesity paradox such that no paradox is observed in individuals who are 
classified as fit [46, 47]. The present findings are in line with our previous report on physical activity 
and VTE risk, where we found that the association was only partly mediated by BMI (14-36%), and 
concluded that the effect of physical activity on VTE risk primarily must be ascribed to mechanisms 
other than obesity [13]. 
 The study by Zöller and colleagues [34] explored the role of familial components on the 
association between CRF and VTE risk. Attenuation of the risk estimates in analyses restricted to 
cousins and full-siblings suggested that the association was partly confounded by familial factors [34]. 
It is well established that the level of CRF in sedentary individuals and the ability to increase CRF with 
exercise demonstrate a high degree of familial aggregation and heritability. The familial resemblance 
of CRF is approximately 50%, and the genetic component is estimated to be 20-30% in sedentary 
individuals [21, 45]. There are also large inter-individual variations in the responses to exercise, with a 
familial resemblance of approximately 50% [48]. The field of exercise genomics is still in its early stages, 
and characterized by underpowered and heterogeneous studies awaiting replication [33, 49]. Although 
we currently are not aware of any genetic variants related to CRF that have been identified in genome-
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wide association studies of VTE, future adequately powered studies may investigate a potential causal 
association between CRF and VTE using a Mendelian randomization design [50-52]. 
 At present, there is a lack of consensus on the definition of low, moderate and high levels of 
CRF [22]. Previous studies on CRF in relation to other health outcomes have used a variety of measures 
such as study-specific percentiles, age-specific cut-off values and absolute cut-offs [23, 28, 53, 54]. In 
the present study, we found that higher eCRF was associated with lower VTE risk when expressed as a 
fraction of age-predicted values, age- and sex-specific categories and per MET increase. However, the 
former approach appeared to be superior as it was most strongly associated with VTE risk and was 
consistently associated with VTE risk across all subcategories. Considering CRF relative to the expected 
values for a healthy individual may not only be an easily communicable format in clinical and public 
health settings [55], but also facilitates for comparison between studies. 
 The main strengths of the present study include participants recruited from a general 
population with a wide age-range, high participation rates and a thoroughly validated outcome. The 
UNN is the only provider of relevant diagnostics and hospital care in the study region, and a near 
complete register may be anticipated. The present study is among the first to present data on the 
association between CRF and VTE risk, and provides highly relevant knowledge to field of lifestyle 
factors and VTE risk. A limitation of the study includes a substantial amount of exclusions (18%) due to 
missing values on variables necessary to estimate CRF. Excluded participants were older and had a less 
favorable cardiovascular risk profile compared with those included. Although this may hamper the 
generalizability of our findings, it is unlikely to be a threat to the internal validity of the study. 
Furthermore, information on physical activity used in the eCRF algorithm was collected via self-report, 
with an inherent chance of information bias. However, given the prospective design of our study, this 
would be non-differential and tend to bias the association towards the null [42]. Finally, due to the 
observational design, there is a chance for residual confounding due to unknown confounders. 
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 In conclusion, we found that higher eCRF, obtained from easily available variables, was 
associated with a lower risk of incident VTE. The association was independent of weight status, 
suggesting that eCRF may counterbalance the elevated VTE risk associated with a high body weight. 
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Tables and Figures 
 
Table 1 Baseline characteristics of participants (n=10,393) by categories of fraction of age-predicted 
cardiorespiratory fitness (CRF); the Tromsø Study (2007-2016).  
 
BMI, body mass index; CVD, cardiovascular disease (angina pectoris, stroke, myocardial infarction); HDL, high-density 
lipoprotein; SD, standard deviation 
†Fifteen or more year of education (corresponding to 3 years in university or academy) 
Values are means ± 1 SD or percentages with counts in parentheses 
   
 
eCRF < 85% 
(n=3,919) 
 eCRF 85-100%  
(n=4,508) 
eCRF > 100%  
(n=1,966) 
eCRF (mL/kg/min) 29.0 ± 4.8  36.5 ± 4.7 43.2 ± 5.7 
Age, years (mean, SD) 57 ± 12 55 ± 12 57 ± 12 
Sex, women (%, n) 71.2 (2,790) 52.0 (2,342) 19.6 (385) 
BMI, kg/m2 (mean, SD) 29.5 ± 4.4 25.6 ± 3.1 24.1 ± 2.6 
Triglycerides, mmol/L (mean, SD) 1.74 ± 1.16 1.43 ± 0.87 1.25 ± 0.74 
Total cholesterol, mmol/L (mean, SD)  5.73 ± 1.11 5.54 ± 1.08 5.44 ± 1.02 
HDL cholesterol, mmol/L (mean, SD) 1.44 ± 0.41 1.54 ± 0.45 1.60 ± 0.44 
Systolic blood pressure, mmHg (mean, SD) 138 ± 23 132 ± 22 133 ± 22 
Smoking (%, n) 20.9 (817) 19.0 (855) 13.4 (264) 
Higher education† (%, n) 33.9 (1,314) 44.0 (1,975) 50.6 (988) 
History of CVD  (%, n) 8.8 (346) 8.3 (372) 10.3 (202) 
History of cancer (%, n) 6.3 (247) 5.6 (252) 6.1 (120) 
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Table 2 Characteristics of venous thromboembolism (VTE) events (n=176);  
the Tromsø Study (2007-2016)  
 
 % (n) 
Age, years (mean, SD) 69 ± 11 
Sex (men) 55.1 (97) 
Clinical characteristics  
   Pulmonary embolism 56.3 (99) 
   Deep vein thrombosis 43.7 (77) 
   Provoked 60.8 (107) 
   Unprovoked* 39.2 (69)  
Provoking factors†  
   Surgery 17.1 (30) 
   Trauma 11.4 (20) 
   Acute medical condition 9.1 (16) 
   Cancer  30.7 (54) 
   Immobilization‡ 14.2 (25) 
   Other§ 6.8 (12) 
Clinical risk factors  
   Estrogens (HRT, oral contraceptives) 3.8 (3) 
   Heredity¶ 4.0 (7) 
   Pregnancy/postpartum 1.1 (2) 
   Other medical conditions** 21.3 (23) 
 
HRT, hormone replacement therapy; SD, standard deviation; VTE, venous thromboembolism 
*No provoking factors at the time of diagnosis 
†One patient may have multiple provoking factors 
‡Bed rest ≥3 days, long-distance travel ≥4 h within the previous 14 days, or confined to wheelchair 
§Other factors specified as provoking in the medical record (e.g., intravascular catheters) 
¶Reported family history of VTE in first-degree relative(s) before the age of 60 
**Other diseases within the previous year (myocardial infarction, ischemic stroke heart failure, inflammatory bowel 
disease, or myeloproliferative disorders) 




Table 3 Incidence rates (IRs) and hazard ratios (HRs) with 95% confidence intervals (CIs) of venous 
thromboembolism (VTE) according to percentage of age-predicted cardiorespiratory fitness (CRF); 
the Tromsø Study (2007-2016) 
Fraction of age- 
predicted  CRF 
Person-
years 
VTE events Crude IR (95% CI) HR (95% CI)* HR (95% CI)† 
Total VTE      
   <85% 31339 94 3.00 (2.45-3.67) 1 1 
   85-100% 36438 60 1.65 (1228-2.12) 0.54 (0.39-0.77) 0.54 (0.39-0.76) 
   >100% 15951 22 1.38 (0.91-2.09) 0.33 (0.20-0.54) 0.33 (0.20-0.54) 
   Per 1 MET 83729 176 2.10 (1.81-2.44) 0.75 (0.67-0.83) 0.75 (0.67-0.83) 
Provoked VTE      
   <85% 31339 57 1.82 (1.40-2.36) 1 1 
   85-100% 36438 34 0.93 (0.67-1.31) 0.53 (0.34-0.82) 0.52 (0.33-0.81) 
   >100% 15951 16 1.00 (0.61-1.64) 0.41 (0.23-0.75) 0.41 (0.23-0.75) 
   Per 1 MET 83729 107 1.28 (1.06-1.54) 0.76 (0.66-0.87) 0.76 (0.66-0.87) 
Unprovoked VTE      
   <85% 31339 37 1.18 (0.86-1.63) 1 1 
   85-100% 36438 26 0.71 (0.49-1.05) 0.58 (0.34-0.97) 0.57 (0.34-0.96) 
   >100% 15951 6 0.38 (0.17-0.84) 0.22 (0.09-0.54) 0.22 (0.09-0.53) 
   Per 1 MET 83729 69 0.82 (0.65-1.04) 0.73 (0.62-0.87) 0.73 (0.61-0.86) 
Pulmonary embolism      
   <85% 31339 51 1.63 (1.24-2.14) 1 1 
   85-100% 36438 35 0.96 (0.69-2.14) 0.56 (0.36-0.88) 0.55 (0.35-0.86) 
   >100% 15951 13 0.81 (0.47-1.40) 0.32 (0.17-0.61) 0.32 (0.17-0.61) 
   Per 1 MET 83729 99 1.18 (0.97-1.40) 0.72 (0.62-0.83) 0.72 (0.62-0.83) 
Deep vein thrombosis      
   <85% 31339 43 1.37 (1.02-1.85) 1 1 
   85-100% 36438 25 0.67 (0.46-1.02) 0.53 (0.32-0.88) 0.52 (0.31-0.87) 
   >100% 15951 9 0.56 (0.29-1.08) 0.35 (0.16-0.75) 0.35 (0.16-0.75) 
   Per 1 MET 83729 77 0.92 (0.74-1.15) 0.79 (0.67-0.93) 0.79 (0.67-0.93) 
MET, metabolic equivalent (3.5 mL/kg/min) 
*Adjusted for age (as timescale) and sex.  





Figure 1 Incidence rates (IRs) and hazard ratios (HRs) with 95% confidence intervals (CIs) of venous 
thromboembolism (VTE) by percentage of age-predicted cardiorespiratory fitness (CRF) and weight 
status; the Tromsø Study (2007-2016). The regression model is adjusted for age (as timescale) and 
sex. 
 
 
 
 
 
 
 
 
